Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 12;15(1):106.
doi: 10.1186/s13550-025-01300-z.

Deep learning-based radiolabelled compound-protein interaction prediction for NDUFS1-targeting radiopharmaceutical discovery

Muath Almaslamani  1   2 , Jingyu Yang  1 , Chi Soo Kang  1   2 , Choong Mo Kang  1   2 , Jung Mi Park  3 , Sang-Keun Woo  4   5
Affiliations

Deep learning-based radiolabelled compound-protein interaction prediction for NDUFS1-targeting radiopharmaceutical discovery

Muath Almaslamani et al. EJNMMI Res. .

Abstract

Background: NDUFS1 is the largest subunit of OXPHOS complex I (MC-I) and mutations in this gene are associated with MC-I deficiency. This study aims to develop a graph neural network and attention mechanism-based radiopharmaceutical-protein (RP-protein) interaction prediction model for identifying an imaging candidate of mitochondrial function through targeting its core subunit NDUFS1.

Results: The estimated cell viability values for trastuzumab, 177Lu-DOTA-trastuzumab, and 225Ac-DOTA-trastuzumab were 290.1, 89.01, and 8.262 nM, respectively. The deep learning (DL) model was pretrained with normal compound-protein pairs. Afterwards, the model was fine-tuned with the dataset of RP-protein pairs and evaluated with five-fold cross validation. The prediction model trained with normal compound-protein pairs effectively predicted the binding affinity. The fine-tuned model incorporating radioactive properties outperformed the same model trained only on normal compounds. The model estimated the important substructure of a compound related to its binding to the target protein. NDUFS1 protein-targeting compounds were identified and BDBM210829 compound had the best binding affinities, binding rank, and LogP as it binds to the NDUFS1.

Conclusions: This study proposed a DL-based radiolabelled compound-protein interaction prediction model to identify a radiopharmaceutical (RP) that binds to the mitochondrial core subunit NDUFS1. The proposed model shows good performance for predicting RP-protein interaction. BDBM210829 was identified as a top candidate for radiolabeling and targeting the mitochondrial core subunit NDUFS1. This model can be used as an effective virtual screening tool for RP discovery.

Supplementary Information: The online version contains supplementary material available at 10.1186/s13550-025-01300-z.

Keywords: Binding affinity; Compound protein interaction; Graph neural network; Mitochondria; NDUFS1; Radiopharmaceutical discovery.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study was approved by the Institutional Review Board of KIRAMS (IRB No.: 2022-09-006-002). All methods were performed in accordance with the relevant guidelines and regulations. Consent for publication: Informed consent was obtained from all participants involved in the study. Competing interests: The authors have declared that no competing interest exists. Clinical trial number: Not applicable.

Figures

Fig. 1
Fig. 1
Network architecture of the radiopharmaceutical-compound interaction prediction model
Fig. 2
Fig. 2
Scatter plot of the predicted natural log of binding affinities by the prediction model and their ground-truth of the normal test dataset. A: Ki; B: Kd
Fig. 3
Fig. 3
Binding affinity with corresponding ranking of NDUFS1-binding compounds identified by the proposed model
Fig. 4
Fig. 4
Chemical structure of top 8 selected NDUFS1-binding compounds identified by the proposed model. (A) BDBM85009, (B) BDBM210829, (C) CYN154806, (D) BDBM214012, (E) BDBM214042, (F) CID135423658, (G) CHEMBL4290888, and (H) CHEMBL3605412
Fig. 5
Fig. 5
Docking simulation results using AutoDock 4 of compounds binding to NDUFS1 protein. Dotted yellow line indicates the docking site of the pair. (A) BDBM210829; (B) BDBM214042; (C) Rotenone; (D) BDBM210829-NDUFS1 interactions
See this image and copyright information in PMC

References

    1. Chhikara BS, Parang K. Global cancer statistics 2022: the trends projection analysis. Chem Biol Lett. 2023;10(1):451.
    1. Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, et al. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of Metformin in tumor tissue. Cell Cycle. 2011;10(23):4047–64. 10.4161/cc.10.23.18151. - DOI - PMC - PubMed
    1. Mondal SK, Haas D, Han J, Whiteside TL. Small EV in plasma of triple negative breast cancer patients induce intrinsic apoptosis in activated T cells. Commun Biol. 2023;6(1):815. 10.1038/s42003-023-05169-3. - DOI - PMC - PubMed
    1. Mimaki M, Wang X, McKenzie M, Thorburn DR, Ryan MT. Understanding mitochondrial complex I assembly in health and disease. Biochim Biophys Acta. 2012;1817(6):851–62. 10.1016/j.bbabio.2011.08.010. - DOI - PubMed
    1. Read AD, Bentley RE, Archer SL, Dunham-Snary KJ. Mitochondrial iron–sulfur clusters: structure, function, and an emerging role in vascular biology. Redox Biol. 2021;47:102164. 10.1016/j.redox.2021.102164. - DOI - PMC - PubMed

LinkOut - more resources